Evidence map›Paper›PMID 39937302›Full record

ArticleDiscover oncology2025

A deep learning model to predict dose distributions for breast cancer radiotherapy.

Xiaorong Hou, Weishi Cheng, Jing Shen, Hui Guan, Yimeng Zhang, Lu Bai, Shaobin Wang, Zhikai Liu

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaorong Hou *Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Weishi Cheng *Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Jing ShenDepartment of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Hui GuanDepartment of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Yimeng ZhangMedMind Technology Co. Ltd., AB 1920 Techart Plaza, Beijing, 100083, China.
Lu BaiMedMind Technology Co. Ltd., AB 1920 Techart Plaza, Beijing, 100083, China.
Shaobin WangMedMind Technology Co. Ltd., AB 1920 Techart Plaza, Beijing, 100083, China.
Zhikai LiuDepartment of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. liuzk2009@126.com.

Funding

National High Level Hospital Clinical Research Funding 2022-PUMCH-A-104
6 · The paper itself

Abstract

purposeIn this work, we propose to develop a 3D U-Net-based deep learning model that accurately predicts the dose distribution for breast cancer radiotherapy.

methodsThis study included 176 breast cancer patients, divided into training, validating and testing sets. A deep learning model based on the 3D U-Net architecture was developed to predict dose distribution, which employed a double encoder combination attention (DECA) module, a cross stage partial + Resnet + Attention (CRA) module, a difficulty perception and a critical regions loss. The performance and generalization ability of this model were evaluated by the voxel mean absolute error (MAE), several clinically relevant dosimetric indexes and 3D gamma passing rates.

resultsOur model accurately predicted the 3D dose distributions with each dosage level mirroring the clinical reality in shape. The generated dose-volume histogram (DVH) matched with the ground truth curve. The total dose error of our model was below 1.16 Gy, complying with clinical usage standards. When compared to other exceptional models, our model optimally predicted eight out of nine regions, and the prediction errors for the first planning target volume (PTV1) and PTV2 were merely 1.03 Gy and 0.74 Gy. Moreover, the mean 3%/3 mm 3D gamma passing rates for PTV1, PTV2, Heart and Lung L achieved 91.8%, 96.4%, 91.5%, and 93.2%, respectively, surpassing the other models and meeting clinical standards.

conclusionsThis study developed a new deep learning model based on 3D U-Net that can accurately predict dose distributions for breast cancer radiotherapy, which can improve the quality and planning efficiency.

Indexed as

Breast cancerDeep learningDose optimization and planningDose prediction

Identifiers

PMID39937302
PMCPMC11822156

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.